“We remain committed to sustainable healthcare and believe TECENTRIQ SC will play a critical role in freeing up infusion chairs and reducing the strain on cancer services," said Nic Horridge, the general manager of Roche Pharmaceuticals Australia.
Government funds first immunotherapy subcutaneous injection via the PBS
August 1, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
New Zealand to streamline access to ADHD treatments
June 26, 2025 - - Latest News -
CLEO strengthens FDA submission following Access to globally recognised Biobank
June 25, 2025 - - Australian Biotech -
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - - Latest News -
QBiotics' candidate produces strong efficacy result in soft tissue sarcoma trial
June 25, 2025 - - Latest News -
Noxopharm says clinical trial recruitment progressing rapidly
June 25, 2025 - - Australian Biotech -
AusBiotech leads global engagement to strengthen Australia's life sciences sector
June 25, 2025 - - Australian Biotech -
NT doctors want action as whooping cough cases soar
June 25, 2025 - - Latest News